Asaoka M, Ishikawa T, Takabe K, Patnaik SK. APOBEC3-Mediated RNA Editing in Breast Cancer is Associated with Heightened Immune Activity and Improved Survival. International Journal of Molecular Sciences. 2019. 20. 22
Ueda A, Oikawa K, Fujita K, Ishikawa A, Sato E, Ishikawa T, Kuroda M, Kanekura K. Therapeutic potential of PLK1 inhibition in triple-negative breast cancer. Lab Invest. 2019. 99. 9. 1275-1286
Prospective Cohort Study of Febrile Neutropenia in Breast Cancer Patients with Neoadjuvant and Adjuvant Chemotherapy: CSPOR=BC FN Study
(2019 San Antonio Breast Cancer Symposium 2019)
Management of Febrile Neutropenia in Breast Cancer Patients with Neoadjuvant and Adjuvant Chemotherapy.
(2019 Taipei International Breast Cancer Symposium (TIBCS) 2019)
Chemotherapy as Partner of Immunotherapy for Advanced Her2 Negative Breast Cancer
(2019 Taipei International Breast Cancer Symposium (TIBCS) 2019)
Indication of Nipple Sparing Mastectomy and Reconstruction in Young Breast Cancer Patients.
(Taiwan Oncoplastic Breast Surgery Society 2018 Annual Meeting 2018)
High APOBEC3C-H gene expression in tumor associates with better survival in breast cancer
(2018 San Antonio Breast Cancer Symposium 2018)